Authorized purpose: The Clarius Ultrasound System is a software-based ultrasound imaging system and accessories for point-of-care imaging of medical conditions, including emergency triage for trauma, needle guidance, and targeted fetal, abdominal, small-organ, musculoskeletal, urology, gynecology, adult and pediatric cardiac, peripheral-vessel, pediatric, and carotid applications. It is intended for trained medical professionals in professional healthcare facilities and is not intended for emergency medical service, ambulance, or aircraft use.
Clinical role
Point-of-care diagnostic imaging, fluid-flow analysis, targeted measurement, and needle or catheter guidance.
Images and patients
Ultrasound · General human-body anatomy; listed point-of-care ultrasound applications
Key limitation
Keep in mind: The FDA package excludes ophthalmic, intraoperative, endocavitary, open-wound, transport, and out-of-facility emergency uses; patient artifacts and other listed contraindications can produce inaccurate results.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: The Clarius Ultrasound System is a software-based ultrasound imaging system and accessories for point-of-care imaging of medical conditions, including emergency triage for trauma, needle guidance, and targeted fetal, abdominal, small-organ, musculoskeletal, urology, gynecology, adult and pediatric cardiac, peripheral-vessel, pediatric, and carotid applications. It is intended for trained medical professionals in professional healthcare facilities and is not intended for emergency medical service, ambulance, or aircraft use.
Which images or clinical context are in scope?Modality: Ultrasound Anatomy or clinical context: General human-body anatomy; listed point-of-care ultrasound applications Input: Ultrasound echoes acquired by supported wireless transducers and user-selected clinical applications.
Who uses it?Intended users: Trained medical professionals such as physicians, nurses, and technicians.
What does the software produce?Output: High-resolution real-time ultrasound images and fluid-flow information displayed on compatible iOS or Android devices.
What is its most important limitation?Key limitation: The FDA package excludes ophthalmic, intraoperative, endocavitary, open-wound, transport, and out-of-facility emergency uses; patient artifacts and other listed contraindications can produce inaccurate results.
Clinical takeaway. Clinical role: The Clarius Ultrasound System is a software-based ultrasound imaging system and accessories for point-of-care imaging of medical conditions, including emergency triage for trauma, needle guidance, and targeted fetal, abdominal, small-organ, musculoskeletal, urology, gynecology, adult and pediatric cardiac, peripheral-vessel, pediatric, and carotid applications. It is intended for trained medical professionals in professional healthcare facilities and is not intended for emergency medical service, ambulance, or aircraft use.
Evidence takeaway. Evidence from the reviewed source record: The exact FDA document reports only non-clinical performance testing: tests showing compliance with IEC 60601-1 (basic safety and essential performance), IEC 60601-1-2 (electromagnetic requirements), the Part 2-37 particular requirements for ultrasonic medical diagnostic and monitoring equipment, and ISO 10993-1 (biological evaluation), plus quality assurance measures including risk analysis, product specifications, design reviews, and verification and validation. Results are as reported in the FDA submission, not independent validation.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
The Clarius Ultrasound System is a software-based ultrasound imaging system and accessories for point-of-care imaging of medical conditions, including emergency triage for trauma, needle guidance, and targeted fetal, abdominal, small-organ, musculoskeletal, urology, gynecology, adult and pediatric cardiac, peripheral-vessel, pediatric, and carotid applications. It is intended for trained medical professionals in professional healthcare facilities and is not intended for emergency medical service, ambulance, or aircraft use.
The FDA package excludes ophthalmic, intraoperative, endocavitary, open-wound, transport, and out-of-facility emergency uses; patient artifacts and other listed contraindications can produce inaccurate results.
The exact FDA document reports only non-clinical performance testing: tests showing compliance with IEC 60601-1 (basic safety and essential performance), IEC 60601-1-2 (electromagnetic requirements), the Part 2-37 particular requirements for ultrasonic medical diagnostic and monitoring equipment, and ISO 10993-1 (biological evaluation), plus quality assurance measures including risk analysis, product specifications, design reviews, and verification and validation. Results are as reported in the FDA submission, not independent validation.
Exact FDA submission
Checked 2026-11-14
Packet wording: "Non-clinical performance tests relied on this premarket notification submission for a determination of substantial equivalence include rests which show compliance to the following standards:" … "Medical electrical equipment – Part 1: General requirements for basic safety IEC 60601-1 2012 and essential performance.". Read from the exact FDA decision document on 2026-11-14.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
The exact FDA document reports only non-clinical performance testing: tests showing compliance with IEC 60601-1 (basic safety and essential performance), IEC 60601-1-2 (electromagnetic requirements), the Part 2-37 particular requirements for ultrasonic medical diagnostic and monitoring equipment, and ISO 10993-1 (biological evaluation), plus quality assurance measures including risk analysis, product specifications, design reviews, and verification and validation. Results are as reported in the FDA submission, not independent validation.
FDA source
Exact FDA submission
Checked 2026-11-14
Packet wording: "Non-clinical performance tests relied on this premarket notification submission for a determination of substantial equivalence include rests which show compliance to the following standards:" … "Medical electrical equipment – Part 1: General requirements for basic safety IEC 60601-1 2012 and essential performance.". Read from the exact FDA decision document on 2026-11-14.
Sensitivity is not promoted as a product-wide endpoint. Compare only an exact endpoint, threshold, population, version, study design, and source if separately verified.
Reported specificity
Not applicable
Not applicable
Not applicable
Checked 2026-09-04
Specificity is not promoted as a product-wide endpoint. Compare only an exact endpoint, threshold, population, version, study design, and source if separately verified.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
K163138 FDA evidence package for Clarius Ultrasound System
DesignFDA 510(k) diagnostic-ultrasound indications and substantial-equivalence evidence for the C3 and L7 transducers and software system.
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
The 2026-09-02 openFDA device-recall snapshot contained no record matched to K163138 by exact native submission identifier. This does not exclude product-family, later-version, or adverse-event information.
Public source
Exact FDA submission
Checked 2026-09-04
Exact-identifier review does not prove absence of all product-family safety signals.
No separate named-product Medicare payment was identified in the reviewed CMS coverage material. Evaluate the product within the applicable imaging or clinical service line and verify payer, site-of-service, coding, and coverage assumptions independently.
No separate named-product payment identified in reviewed public material
Centers for Medicare & Medicaid Services · United States
This is not a product-specific reimbursement determination. Build a local total-cost and value model and verify payer, site-of-service, coding, and coverage assumptions independently.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: Ultrasound echoes acquired by supported wireless transducers and user-selected clinical applications.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: The FDA package describes wireless transducers communicating by Wi-Fi Direct with compatible iOS or Android viewing devices and export of ultrasound images to portable personal devices.
Scope: Exact FDA submission. This is the interface boundary described in the exact FDA package; current local compatibility, routing, identity, archive, and downtime behavior still require acceptance testing.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Source context, not route validation: The FDA package describes a wireless transducer, removable battery and charger, and compatible commercial iOS or Android viewing device used in professional healthcare facilities; current mobile software release, hosting, service, security, availability, and site configuration remain unverified.
Scope: Exact FDA submission. This is the release-level boundary described in the exact FDA package; current hosting, contracts, security, availability, upgrade path, and site configuration remain separate evidence.
Confirm processing location, queue ownership, exclusions and exact AI build.
Source context, not route validation: High-resolution real-time ultrasound images and fluid-flow information displayed on compatible iOS or Android devices.
Scope: Exact FDA submission.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Unresolved route: High-resolution real-time ultrasound images and fluid-flow information displayed on compatible iOS or Android devices.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
The FDA package describes a wireless transducer, removable battery and charger, and compatible commercial iOS or Android viewing device used in professional healthcare facilities; current mobile software release, hosting, service, security, availability, and site configuration remain unverified.
Exact FDA submission
Checked 2026-09-04
This is the release-level boundary described in the exact FDA package; current hosting, contracts, security, availability, upgrade path, and site configuration remain separate evidence.
The FDA package describes wireless transducers communicating by Wi-Fi Direct with compatible iOS or Android viewing devices and export of ultrasound images to portable personal devices.
Exact FDA submission
Checked 2026-09-04
This is the interface boundary described in the exact FDA package; current local compatibility, routing, identity, archive, and downtime behavior still require acceptance testing.
Clarius's support article on cloud data security says Clarius Cloud data is stored in AWS data centers in a customer-chosen region (Canada, United States Oregon, EU Frankfurt or Australia), exams can be sent to PACS by DICOM with cloud storage disabled, activity logs are kept for six months, patient information is stored for seven years, backups run hourly and are kept 365 days, and an independent third party validates security. No certification is named, and the information security whitepaper it cites was not read.
Vendor-wide
Checked 2026-10-25
Vendor-wide statement, not an independent attestation. It does not establish certificate or report scope for this exact release, expiry, data location, retention, identity and access, or incident-response terms for a deployed configuration. Obtain these from the vendor.
Only trained medical professionals such as physicians, nurses, and technicians should operate or interpret the product. Local onboarding should cover the exact release, supported population, limitations, failure examples, escalation, downtime, and competency documentation.
Monitor K163138 by exact hardware, software, model, and algorithm version; patient population; anatomy; protocol; operator; input quality; output edits or overrides; failed studies; repeat acquisition or rework; downstream impact; downtime; incidents; recalls; and updates. Track these product-specific limits: The FDA package excludes ophthalmic, intraoperative, endocavitary, open-wound, transport, and out-of-facility emergency uses; patient artifacts and other listed contraindications can produce inaccurate results.
Exact FDA submission
Checked 2026-09-04
This is buyer-facing monitoring guidance derived from the exact cleared or authorized scope; it is not a claim that the FDA package provides a live monitoring service.
The FDA package describes a wireless transducer, removable battery and charger, and compatible commercial iOS or Android viewing device used in professional healthcare facilities; current mobile software release, hosting, service, security, availability, and site configuration remain unverified.
exact submission · checked 2026-09-04
FDA-described deployment boundaries do not establish current hosting contracts, security controls, uptime, or local qualification.
The FDA package describes wireless transducers communicating by Wi-Fi Direct with compatible iOS or Android viewing devices and export of ultrasound images to portable personal devices.
exact submission · checked 2026-09-04
Test representative identifiers, orientation, geometry, measurements, units, routing, failure handling, and round trips locally.
Use a signed local test set for the supported population and workflow. Include common and difficult cases, exclusions, acquisition variation, failed or low-quality inputs, reviewer overrides, and downstream effects. The FDA package excludes ophthalmic, intraoperative, endocavitary, open-wound, transport, and out-of-facility emergency uses; patient artifacts and other listed contraindications can produce inaccurate results.
exact submission · checked 2026-09-04
Define stop-use, escalation, rollback, and revalidation triggers before production use.
Model capital and recurring cost against net staff time after review, throughput, repeat imaging or rework, room time, consumables, infrastructure, training, service, downtime, upgrade, and replacement costs.
product family · checked 2026-09-04
No exact-product price was found in the reviewed public material; productivity or value claims require local evidence.
Monitor K163138 by exact hardware, software, model, and algorithm version; patient population; anatomy; protocol; operator; input quality; output edits or overrides; failed studies; repeat acquisition or rework; downstream impact; downtime; incidents; recalls; and updates. Track these product-specific limits: The FDA package excludes ophthalmic, intraoperative, endocavitary, open-wound, transport, and out-of-facility emergency uses; patient artifacts and other listed contraindications can produce inaccurate results.
exact submission · checked 2026-09-04
Revalidate after material software, hardware, model, protocol, interface, or clinical-policy changes. point-of-care diagnostic ultrasound imaging system limits remain submission-specific.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Human reviewedStatus
2026-09-04Last searched
26Fields reviewed
12Source classes checked
0Screened PubMed leads
1Screened trial leads
0Unreviewed FDA recall leads
One trial record was screened. It uses an unspecified Clarius ultrasound system and linear transducer for musculoskeletal measurements but does not identify the K163138 system configuration; the record is quarantined. The current discovery snapshot contains 0 PubMed and 1 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, vendor documentation, fda decision material, fda pma record, peer reviewed literature, clinical trial registry, reimbursement policy, fda device recall, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not publicly available - checked 2026-09-04 - Exact FDA submission
No public list price for the exact cleared or authorized configuration was found. Obtain a written quote separating hardware or license basis, implementation, interfaces, infrastructure, training, service, upgrades, renewal, consumables, and exit costs.
Authorized purpose: Alturion Series diagnostic ultrasound systems acquire and display ultrasound images and fluid-flow information for the labeled fetal, abdominal, cardiac, cephalic, obstetric, musculoskeletal, ophthalmic, urologic, vascular, small-organ, and lung examinations.
Modality
Ultrasound
Anatomy
Fetus; abdomen; pelvis; small organs; head; heart; peripheral vessels; musculoskeletal anatomy; ophthalmic; urologic organs; and lung
Authorized purpose: WatchMate Software v1.2.0 processes transesophageal echocardiography data to reconstruct the left atrial appendage and assist preprocedural planning and device sizing during left-atrial-appendage closure.
Authorized purpose: Guides medical professionals acquiring ten standard 2D transthoracic echocardiographic views in adults requiring a cardiac ultrasound examination; acquired images require qualified clinical interpretation.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.